Roku (NASDAQ: ROKU) reported third-quarter 2020 financial results after the regular trading hours on Thursday. The online streaming firm reported a 73% growth in Q3 revenue to $452 million, surpassing the Wall Street consensus. The company reported a net income of $0.09 per share, even as analysts expected a loss.
ROKU shares shot up 9.5% immediately following the announcement. The stock has gained 64% since the beginning of this year.
The company said in a statement, “During the quarter, we achieved a 43% year-over-year active account growth rate and doubled the active account reach of The Roku Channel. Despite continued uncertainties caused by the pandemic, we are pleased with the trajectory of our business and believe that Roku remains well positioned to help shape the future of television – including TV advertising – around the world.”
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated